Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration)

NCT00996944 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
34
Enrollment
INDUSTRY
Sponsor class

Stopped Because GSK concluded that it was impossible to recruit sufficient participants within a reasonable timeframe.

Conditions

Interventions

Sponsor

GlaxoSmithKline